Reversible Major Histocompatibility Complex I-peptide Multimers Containing Ni(2+)-nitrilotriacetic Acid Peptides and Histidine Tags Improve Analysis and Sorting of CD8(+) T Cells
Overview
Authors
Affiliations
MHC-peptide multimers containing biotinylated MHC-peptide complexes bound to phycoerythrin (PE) streptavidin (SA) are widely used for analyzing and sorting antigen-specific T cells. Here we describe alternative T cell-staining reagents that are superior to conventional reagents. They are built on reversible chelate complexes of Ni(2+)-nitrilotriacetic acid (NTA) with oligohistidines. We synthesized biotinylated linear mono-, di-, and tetra-NTA compounds using conventional solid phase peptide chemistry and studied their interaction with HLA-A*0201-peptide complexes containing a His(6), His(12), or 2×His(6) tag by surface plasmon resonance on SA-coated sensor chips and equilibrium dialysis. The binding avidity increased in the order His(6) < His(12) < 2×His(6) and NTA(1) < NTA(2) < NTA(4), respectively, depending on the configuration of the NTA moieties and increased to picomolar K(D) for the combination of a 2×His(6) tag and a 2×Ni(2+)-NTA(2). We demonstrate that HLA-A2-2×His(6)-peptide multimers containing either Ni(2+)-NTA(4)-biotin and PE-SA- or PE-NTA(4)-stained influenza and Melan A-specific CD8+ T cells equal or better than conventional multimers. Although these complexes were highly stable, they very rapidly dissociated in the presence of imidazole, which allowed sorting of bona fide antigen-specific CD8+ T cells without inducing T cell death as well as assessment of HLA-A2-peptide monomer dissociation kinetics on CD8+ T cells.
Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.
Couturaud B, Doix B, Carretero-Iglesia L, Allard M, Pradervand S, Hebeisen M Front Immunol. 2023; 14:1293090.
PMID: 38053994 PMC: 10694213. DOI: 10.3389/fimmu.2023.1293090.
Schmidt J, Chiffelle J, Perez M, Magnin M, Bobisse S, Arnaud M Nat Commun. 2023; 14(1):3188.
PMID: 37280206 PMC: 10244384. DOI: 10.1038/s41467-023-38946-z.
Bystander T cells in cancer immunology and therapy.
Meier S, Satpathy A, Wells D Nat Cancer. 2022; 3(2):143-155.
PMID: 35228747 DOI: 10.1038/s43018-022-00335-8.
Duraiswamy J, Turrini R, Minasyan A, Barras D, Crespo I, Grimm A Cancer Cell. 2021; 39(12):1623-1642.e20.
PMID: 34739845 PMC: 8861565. DOI: 10.1016/j.ccell.2021.10.008.
MHC multimer: A Molecular Toolbox for Immunologists.
Chang J Mol Cells. 2021; 44(5):328-334.
PMID: 33972472 PMC: 8175149. DOI: 10.14348/molcells.2021.0052.